Secondary prevention with antiplatelet medications in patients with antiphospholipid antibody-related stroke

Secondary prevention with antiplatelet medications in patients with antiphospholipid antibody-related stroke

Abstract Clinical guidelines recommend warfarin for patients with antiphospholipid syndrome (APS) and ischemic stroke; however, robust evidence is lacking. We investigated the clinical benefits of different categories of antithrombotic medications in ischemic stroke patients positive for antiphospho...

Full description

Bibliographic Details
Main Authors: Wookjin Yang, Matthew Chung, Jiyeon Ha, Dong-Wan Kang, Eung-Joon Lee, Han-Yeong Jeong, Jeong-Min Kim, Keun-Hwa Jung, Seung-Hoon Lee
Format: Article
Language:English
Published: Nature Portfolio 2025-03-01
Series:Scientific Reports
Subjects:
Antiphospholipid syndrome
Hemorrhage
Ischemic stroke
Secondary prevention
Thrombosis
Online Access:https://doi.org/10.1038/s41598-025-91739-w

Internet

https://doi.org/10.1038/s41598-025-91739-w

Similar Items